Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in men living with overactive bladder (OAB) and receiving ...

Cialis, which contains the active ingredient tadalafil, is one of the most popular medications for ED. It belongs to a class ...

Early cancer biomarkers found in urine can improve screening procedures for the all-too-common prostate cancer.

Male health and vitality a serious issues faced by many men in society. For those looking for the right supplement to ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

Recurrence in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer is common, and there have been a lack of alternative treatments to TURBT.

The ongoing phase 2b SunRISe-1 study is assessing TAR-200 intravesical gemcitabine delivery in patients with BCG-unresponsive high-risk NMIBC.